Skin diseases are highly relevant. One third of the population suffers from at least one skin condition1 and incidences of psoriasis2 and atopic dermatitis3 have doubled during the past decades.

Novel biologics and small-molecule inhibitors have revolutionized treatment options and created a billion dollar market with 5 of the top 10 global blockbuster drugs targeting dermatological conditions.4

However, advances in therapeutics outpace diagnostics in dermatology, leaving a significant gap in precision care. To fully unlock the potential of modern drugs, we need molecular diagnostics alongside conventional methods.

Dermagnostix closes this gap with plug-and-play molecular diagnostic solutions that seamlessly integrate into clinical workflows. By delivering objective, actionable molecular insights, we empower healthcare professionals to make confident decisions. At Dermagnostix, dermatology is more than skin deep – it’s about transforming lives through personalized care and cutting-edge technology!